# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA3600873 | VX689 | inhibition | = | 1.08 | % | ALA4808150 | % | Homo sapiens | |||
2. | ALA3600873 | VX689 | inhibition | = | -25.95 | % | ALA4808149 | % | Homo sapiens | |||
3. | ALA3600873 | VX689 | Inhibition | = | 77.92 | % | ALA4303805 | % | Severe acute respiratory syndrome coronavirus 2 | |||
4. | ALA3600873 | VX689 | T/C | = | 32 | % | ALA4266319 | % | Homo sapiens | |||
5. | ALA3600873 | VX689 | T/C | = | 58 | % | ALA4266318 | % | Homo sapiens | |||
6. | ALA3600873 | VX689 | T/C | = | 7 | % | ALA4266317 | % | Homo sapiens | |||
7. | ALA3600873 | VX689 | T/C | = | 35 | % | ALA4266316 | % | Homo sapiens | |||
8. | ALA3600873 | VX689 | T/C | = | 6 | % | ALA4266315 | % | Homo sapiens | |||
9. | ALA3600873 | VX689 | T/C | = | 10 | % | ALA4266314 | % | Homo sapiens | |||
10. | ALA3600873 | VX689 | Ratio IC50 | = | 190 | ALA4266313 | ||||||
11. | ALA3600873 | VX689 | Ratio IC50 | = | 220 | ALA4266312 | ||||||
12. | ALA3600873 | VX689 | IC50 | = | 0.064 | nM | ALA4266311 | 10.19 | nM | Homo sapiens | ||
13. | ALA3600873 | VX689 | Cp | = | 4.4 | uM | ALA4266310 | uM | ||||
14. | ALA3600873 | VX689 | Cp | = | 1.7 | uM | ALA4266309 | uM | ||||
15. | ALA3600873 | VX689 | IC50 | = | 0.74 | uM | ALA4266308 | 6.13 | nM | Homo sapiens | ||
16. | ALA3600873 | VX689 | IC50 | = | 0.45 | uM | ALA4266307 | 6.35 | nM | Homo sapiens | ||
17. | ALA3600873 | VX689 | IC50 | = | 0.56 | uM | ALA4266306 | 6.25 | nM | Homo sapiens | ||
18. | ALA3600873 | VX689 | IC50 | = | 0.52 | uM | ALA4266305 | 6.28 | nM | Homo sapiens | ||
19. | ALA3600873 | VX689 | IC50 | = | 0.42 | uM | ALA4266304 | 6.38 | nM | Homo sapiens | ||
20. | ALA3600873 | VX689 | inhibition | = | -0.12 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 |